# Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

> **NCT00505063** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 76 (actual)

## Conditions studied

- Childhood Cancer
- Multiple Diseases

## Interventions

- **BIOLOGICAL:** Immunization Schedule patients <7 years.
- **BIOLOGICAL:** Immunization Schedule patients > or = to 7 years and <11 years of age
- **BIOLOGICAL:** Immunization Schedule patients > or = to 11 years of age

## Key facts

- **NCT ID:** NCT00505063
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-10
- **Primary completion:** 2025-06-11
- **Final completion:** 2025-06-11
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505063, "Prospective Trial of Vaccine Responses in Childhood Cancer Survivors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00505063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*